Skip to main content Skip to section navigation Skip to footer
chevron_leftBack to Conexeu.com
Conexeu Sciences, Inc. IR Overview
  • Investors
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Executive Team
    • Board of Directors
    • Medical Advisory Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • Tax Documents
  • chevron_leftBack to Conexeu.com

Press Releases

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
May 21, 2026 12:02 pm EDT
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
May 19, 2026 8:30 am EDT
Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants
May 14, 2026 8:30 am EDT
Conexeu Sciences Unveils Defining Commitment: Architecting Bioregeneration(TM)
Nov 20, 2025 9:00 am EST
Conexeu Sciences Signals a Major Breakthrough in 'Personalized Human Tissue Creation'
Nov 5, 2025 7:00 am EST
Conexeu Sciences Inc. Expands Board of Directors with the Appointments of Dr. Aaron Farberg and Dr. Sebastian Purcell
Nov 3, 2025 7:00 am EST
Conexeu Sciences Appoints Miles Harrison as President & Chief Executive Officer, to Shape the Future of True Tissue Regeneration
Oct 16, 2025 9:01 am EDT
Conexeu Sciences Closes Maximum $5M Reg CF Financing
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Conexeu Sciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement